Prulifloxacin
Prulifloxacin (NM441) is an orally active fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and -negative bacteria. Prulifloxacin is a proagent of a thiazeto-quinoline carboxylic acid derivative Ulifloxacin (NM394) . Prulifloxacin has the potential for lower urinary tract infections and exacerbations of chronic bronchitis[1][2].
Product Specifications
CAS Number
[123447-62-1]
Product Name Alternative
NM441
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Prulifloxacin.html
Concentration
10mM
Purity
98.05
Solubility
DMSO : 12.5 mg/mL (ultrasonic)
Smiles
O=C(C1=C(SC2C)N2C3=C(C=C(F)C(N4CCN(CC5=C(C)OC(O5)=O)CC4)=C3)C1=O)O
Molecular Formula
C21H20FN3O6S
Molecular Weight
461.46
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Quinolone
Available Sizes
Explore Other Products
Browse additional items from our catalog
Rgs16 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
TICAM1 (Trif, MGC35334, TICAM-1, PRVTIRB, Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta, TIR domain-containing adapter protein inducing IFN-beta, TIR DOMAIN-CONTAINING ADAPTOR INDUCING INTERFERON-BETA)
